IGFBP7 Regulates the Osteogenic Differentiation of Bone Marrow‐derived Mesenchymal Stem Cellsviawnt/β‐catenin Signaling Pathway

Wei Zhang,Erman Chen,Mo Chen,Chenyi Ye,Yiying Qi,Qianhai Ding,Hang Li,Deting Xue,Xiang Gao,Zhijun Pan
DOI: https://doi.org/10.1096/fj.201700998rr
2018-01-01
Abstract:Insulin-like growth factor-binding protein 7 (IGFBP7), a low-affinity IGF binder, may play an important role in bone metabolism. However, its function in osteogenic differentiation of human bone marrow-derived mesenchymal stem cells (BMSCs) remains unclear. Therefore, we investigated its effects on osteogenic differentiation. Overexpression of IGFBP7 enhanced the expression of osteo-specific genes and proteins, and IGFBP7 knockdown decreased osteogenesis-specific markers. More mineral deposits and higher alkaline phosphatase activity were observed after the up-regulation of IGFBP7. Moreover, beta-catenin levels were up-regulated by the overexpression of IGFBP7 or the addition of extracellular IGFBP7 protein and were reduced by the depletion of IGFBP7. The increase in osteogenic differentiation due to the overexpression of IGFBP7 was partially decreased by specific Wnt/beta-catenin signaling inhibitors. Using a rat tibial osteotomy model, a sheet of IGFBP7-overexpressing BMSCs improved bone healing, as demonstrated by imaging, biomechanical, and histologic analyses. Taken together, these findings indicate that IGFBP7 regulates the osteogenic differentiation of BMSCs partly via the Wnt/-catenin signaling pathway.
What problem does this paper attempt to address?